New data presented at AACR shows enhanced T cell functionality of MDG1015 in solid tumors
New data presented at AACR shows enhanced T cell functionality of MDG1015 in solid tumors Martinsried/Munich, April 18, 2023, Medigene AG (Medigene, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid tumors, today presents pre...
Source: pharmiweb.com